GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Touyun Biotech Group Ltd (HKSE:01332) » Definitions » EV-to-EBIT

Touyun Biotech Group (HKSE:01332) EV-to-EBIT : -3.75 (As of May. 05, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Touyun Biotech Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Touyun Biotech Group's Enterprise Value is HK$994.2 Mil. Touyun Biotech Group's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-265.2 Mil. Therefore, Touyun Biotech Group's EV-to-EBIT for today is -3.75.

The historical rank and industry rank for Touyun Biotech Group's EV-to-EBIT or its related term are showing as below:

HKSE:01332' s EV-to-EBIT Range Over the Past 10 Years
Min: -37.15   Med: -3.96   Max: 179.01
Current: -3.75

During the past 13 years, the highest EV-to-EBIT of Touyun Biotech Group was 179.01. The lowest was -37.15. And the median was -3.96.

HKSE:01332's EV-to-EBIT is ranked worse than
100% of 329 companies
in the Packaging & Containers industry
Industry Median: 13.41 vs HKSE:01332: -3.75

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Touyun Biotech Group's Enterprise Value for the quarter that ended in Jun. 2023 was HK$1,770.7 Mil. Touyun Biotech Group's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-265.2 Mil. Touyun Biotech Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -14.97%.


Touyun Biotech Group EV-to-EBIT Historical Data

The historical data trend for Touyun Biotech Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Touyun Biotech Group EV-to-EBIT Chart

Touyun Biotech Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.72 -15.10 -37.29 -8.32 -3.83

Touyun Biotech Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -37.29 - -8.32 - -

Competitive Comparison of Touyun Biotech Group's EV-to-EBIT

For the Packaging & Containers subindustry, Touyun Biotech Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Touyun Biotech Group's EV-to-EBIT Distribution in the Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Touyun Biotech Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Touyun Biotech Group's EV-to-EBIT falls into.



Touyun Biotech Group EV-to-EBIT Calculation

Touyun Biotech Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=994.242/-265.153
=-3.75

Touyun Biotech Group's current Enterprise Value is HK$994.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Touyun Biotech Group's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-265.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Touyun Biotech Group  (HKSE:01332) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Touyun Biotech Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 ) =EBIT / Enterprise Value (Q: Jun. 2023 )
=-265.153/1770.6955
=-14.97 %

Touyun Biotech Group's Enterprise Value for the quarter that ended in Jun. 2023 was HK$1,770.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Touyun Biotech Group's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-265.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Touyun Biotech Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Touyun Biotech Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Touyun Biotech Group (HKSE:01332) Business Description

Traded in Other Exchanges
N/A
Address
6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG
Touyun Biotech Group Ltd, formerly China Touyun Tech Group Ltd, an investment holding company, designs, develops, manufactures, and sells packaging products and point-of-sales display units. It operates with four business segments, Packaging Products, Treasury Investment, QR code business, and Chlamydomonas reinhardtii product business. Through the Packaging Products segment, it offers watch boxes, jewelry boxes, eyewear cases, bags and pouches, and display units whereas the Treasury segment engages in the trading of securities and money lending activities. It derives a majority of its revenue from the Packaging products. The business activity of the group is operated in Hong Kong, Mainland China, North and South America, and other countries.

Touyun Biotech Group (HKSE:01332) Headlines

No Headlines